A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Dec. 5, 2024 — Stem cell transplantation is used to ... the human lifetime could have implications for the treatment of acute myeloid leukemia and ... How Breast Cancer Cells Survive in Bone ...

After 3.5 years of follow-up, there was a 98% rate of minimal residual disease, and 9 patients were still in complete remission.

11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for ... Drug-Delivering Aptamers Target Leukemia Stem Cells for One-Two Knockout Punch ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

Director, Paediatrics, Jaslok Hospital & Research Centre explains how stem cell therapy and regenerative medicine have the ...

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...